Clinical Genomics' Series B Round

Clinical Genomics raised a round of funding on June 01, 2018.

Clinical Genomics owns proprietary technologies designed to improve the early detection of cancer. The company has applied it's methyl-DNA biomarkers for colorectal neoplasia to develop a sensitive an…

Articles about Clinical Genomics' Series B Round: